Cumberland Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,500
Closed -$1.17M 186
2024
Q3
$1.17M Buy
3,500
+1,100
+46% +$418K 0.08% 136
2024
Q2
$988K Buy
2,400
+150
+7% +$59.4K 0.07% 131
2024
Q1
$909K Sell
2,250
-1,500
-40% -$527K 0.07% 138
2023
Q4
$1.15M Hold
3,750
0.11% 115
2023
Q3
$908K Buy
+3,750
New +$959K 0.09% 120

Other funds holding MEDP

Cumberland Partners's MEDP Position: Q4 2024 in Review

Cumberland Partners sold out of Medpace (MEDP) in Q4 2024, closing a stake of 3,500 shares — an estimated $1.17M sold.

Cumberland Partners first reported a position in MEDP in Q3 2023 and held it in 5 quarters. The position peaked at $1.17M in Q3 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Cumberland Partners reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Cumberland Partners sold 3,500 Medpace shares in Q4 2024, an estimated $1.17M.
  • Cumberland Partners first reported a position in Medpace in Q3 2023 and held it in 5 quarters.
  • Cumberland Partners's Medpace position peaked at $1.17M in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Cumberland Partners's 13F filing for Q4 2024, filed 3 Feb 2025.